NCT04661657 is a clinical trial of Transthoracic echocardiogram (TTE) in Covid19, sponsored by Columbia University.

Who is sponsoring NCT04661657?

NCT04661657 is sponsored by Columbia University.

What drugs are being tested in NCT04661657?

Interventions in NCT04661657: Transthoracic echocardiogram (TTE), Cardiovascular Magnetic Resonance (CMR) Imaging.

What condition does NCT04661657 study?

NCT04661657 studies Covid19, Cardiac Disease, Cardiac Arrhythmia, Myocarditis, Left Ventricular Dysfunction.

Is NCT04661657 still recruiting?

NCT04661657 is currently completed. Last updated 6 June 2022.

Last reviewed 2022-06-06 · How we verify

NCT04661657

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry

Completed Last updated 6 June 2022

What this trial tests

trial testing Transthoracic echocardiogram (TTE) in Covid19 in 52 participants. Completed in 22 January 2022.

Timeline

28 December 2020

Primary endpoint
22 January 2022

22 January 2022

Quick facts

Lead sponsor	Columbia University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	52
Start date	28 December 2020
Primary completion	22 January 2022
Estimated completion	22 January 2022
Sites	1 location across United States

Drugs / interventions tested

Transthoracic echocardiogram (TTE)
Cardiovascular Magnetic Resonance (CMR) Imaging

Conditions studied

Covid19 — all drugs for Covid19 →
Cardiac Disease — all drugs for Cardiac Disease →
Cardiac Arrhythmia — all drugs for Cardiac Arrhythmia →
Myocarditis — all drugs for Myocarditis →

Sponsor

Columbia University

Who can join

18 and older, any sex, with Covid19 or Cardiac Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

COLUMBIA CARDS is a pilot study to understand how COVID-19 affects the heart. It is known that COVID-19 can affect the heart in different ways. COLUMBIA CARDS is studying why some COVID-19 survivors develop clinical conditions such as heart inflammation, fluid buildup, blood clots, and other cardiac problems during or after their COVID-19 illness, and why other ones do not. In this study, we will use cardiovascular magnetic resonance (CMR) and transthoracic echocardiography (TTE) to better understand the impact of COVID-19 on the heart.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Cardiac involvement in the long-term implications of COVID-19.
Satterfield BA, Bhatt DL, Gersh BJ. · · 2022 · cited 101× · PMID 34686843 · DOI 10.1038/s41569-021-00631-3
Covid-19 sequelae in working age patients: A systematic review.
d'Ettorre G, Gentilini Cacciola E, Santinelli L, De Girolamo G, et al · · 2022 · cited 29× · PMID 34655247 · DOI 10.1002/jmv.27399
Imaging in the COVID-19 era: Lessons learned during a pandemic.
Sideris GA, Nikolakea M, Karanikola AE, Konstantinopoulou S, et al · · 2021 · cited 7× · PMID 34249239 · DOI 10.4329/wjr.v13.i6.192

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Other Columbia University trials

Trials by the same sponsor.

NCT06558422 — Human Models of Selective Insulin Resistance: Pancreatic Clamp · Phase 1 · not yet recruiting
NCT07264582 — HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking · NA · not yet recruiting
NCT05992415 — Know Your Pressures NYC · NA · not yet recruiting
NCT05645211 — The AgRP and GH/IGF-1 Axis in Children · not yet recruiting
NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04661657 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Columbia University
Last refreshed: 6 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04661657.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing